Andrew B. Singleton

Andrew B. Singleton

Auto-generated profile, based on publicly available information

Andrew B. Singleton

Center for Alzheimer’s and Related Dementias, National Institutes of Health, Bethesda, MD 20892, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2003 in Science
Verified
Journal Article
Open access
PDF file
ASA. B. Singleton
A. B. Singleton
MFMatthew J. Farrer
Matthew J. Farrer
JJJ. Johnson
J. Johnson
ASA. Singleton
A. Singleton
SHS. Hague
S. Hague
KGK. Gwinn-Hardy
K. Gwinn-Hardy

1 September 2014 in Nature Genetics
Verified
Journal Article
Open access
PDF file
MNMike A Nalls
Mike A Nalls
NPNathan Pankratz
Nathan Pankratz
CLChristina M. Lill
Christina M. Lill
CDChuong B Do
Chuong B Do
DHDena G Hernandez
Dena G Hernandez
GDGene P D
Gene P D
Andrew Singleton and colleagues report a large-scale meta-analysis of genome-wide association data in Parkinson's disease using over 13,000 cases and 95,000 controls plus additional samples for replication. They identify 6 new risk loci and replicate 28 independent risk variants for Parkinson's disease across 24 loci. We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common set of 7,893,274 variants across 13,708 cases and 95,282 controls. Twenty-six loci were identified as having genome-wide significant association; these and 6 additional previously reported loci were then tested in an independent set of 5,353 cases and 5,551 controls. Of the 32 tested SNPs, 24 replicated, including 6 newly identified loci. Conditional analyses within loci showed that four loci, including GBA, GAK-DGKQ, SNCA and the HLA region, contain a secondary independent risk variant. In total, we identified and replicated 28 independent risk variants for Parkinson's disease across 24 loci. Although the effect of each individual locus was small, risk profile analysis showed substantial cumulative risk in a comparison of the highest and lowest quintiles of genetic risk (odds ratio (OR) = 3.31, 95% confidence interval (CI) = 2.55–4.30; P = 2 × 10−16). We also show six risk loci associated with proximal gene expression or DNA methylation.

15 November 2009 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JSJavier Simón-Sánchez
Javier Simón-Sánchez
CSClaudia Schulte
Claudia Schulte
JBJose M Bras
Jose M Bras
MSManu Sharma
Manu Sharma
JGJ Raphael Gibbs
J Raphael Gibbs
TGThomas Gasser
Thomas Gasser
Andrew Singleton, Thomas Gasser and colleagues report results of a genome-wide association study of Parkinson's disease among individuals of European ancestry. They find genome-wide significant associations at two loci, SNCA and MAPT, and provide supporting evidence for a new risk locus on 1q32. We performed a genome-wide association study (GWAS) in 1,713 individuals of European ancestry with Parkinson's disease (PD) and 3,978 controls. After replication in 3,361 cases and 4,573 controls, we observed two strong association signals, one in the gene encoding α-synuclein (SNCA; rs2736990, OR = 1.23, P = 2.24 × 10−16) and another at the MAPT locus (rs393152, OR = 0.77, P = 1.95 × 10−16). We exchanged data with colleagues performing a GWAS in Japanese PD cases. Association to PD at SNCA was replicated in the Japanese GWAS1, confirming this as a major risk locus across populations. We replicated the effect of a new locus detected in the Japanese cohort (PARK16, rs823128, OR = 0.66, P = 7.29 × 10−8) and provide supporting evidence that common variation around LRRK2 modulates risk for PD (rs1491923, OR = 1.14, P = 1.55 × 10−5). These data demonstrate an unequivocal role for common genetic variants in the etiology of typical PD and suggest population-specific genetic heterogeneity in this disease.

11 September 2019 in The Lancet Neurology
Verified
Journal Article
Closed access
CBCornelis Blauwendraat
Cornelis Blauwendraat
MNMike A Nalls
Mike A Nalls
ASAndrew B Singleton
Andrew B Singleton

1 February 2011 in The Lancet
Verified
Journal Article
Closed access
ICInternational Parkinson Disease Genomics Consortium
International Parkinson Disease Genomics Consortium
MNMichael A Nalls
Michael A Nalls
VPVincent Plagnol
Vincent Plagnol
DHDena G Hernandez
Dena G Hernandez
MSManu Sharma
Manu Sharma
NWNicholas W Wood
Nicholas W Wood

13 May 2010 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
JGJ. Raphael Gibbs
J. Raphael Gibbs
MBMarcel P. van der Brug
Marcel P. van der Brug
DHDena G. Hernandez
Dena G. Hernandez
BTBryan J. Traynor
Bryan J. Traynor
MNMichael A. Nalls
Michael A. Nalls
ASAndrew B. Singleton
Andrew B. Singleton
A fundamental challenge in the post-genome era is to understand and annotate the consequences of genetic variation, particularly within the context of human tissues. We present a set of integrated experiments that investigate the effects of common genetic variability on DNA methylation and mRNA expression in four human brain regions each from 150 individuals (600 samples total). We find an abundance of genetic cis regulation of mRNA expression and show for the first time abundant quantitative trait loci for DNA CpG methylation across the genome. We show peak enrichment for cis expression QTLs to be approximately 68,000 bp away from individual transcription start sites; however, the peak enrichment for cis CpG methylation QTLs is located much closer, only 45 bp from the CpG site in question. We observe that the largest magnitude quantitative trait loci occur across distinct brain tissues. Our analyses reveal that CpG methylation quantitative trait loci are more likely to occur for CpG sites outside of islands. Lastly, we show that while we can observe individual QTLs that appear to affect both the level of a transcript and a physically close CpG methylation site, these are quite rare. We believe these data, which we have made publicly available, will provide a critical step toward understanding the biological effects of genetic variation. In this paper, we describe a comprehensive assessment of the correlation between common genetic variability across the human genome, gene expression, and DNA methylation, within human brain. We studied the cerebellum, frontal cortex, temporal cortex, and pons regions of 150 individuals (600 tissue samples). In each tissue, we assessed 27,578 DNA methylation sites and the expression level of 22,184 genes. Our research shows that DNA methylation and RNA expression patterns differ between brain regions. Further, we show that DNA genotype is correlated with gene expression and DNA methylation, particularly when the genetic variation is close to the DNA methylation site or gene.